Source: Annual Congress 2005 - CAP: aetiology and management
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
I. Alfageme, M. Merino, N. Reyes, J. Lima (Seville, Spain). Prognostic evaluation of COPD patients with pneumonia. Eur Respir J 2005; 26: Suppl. 49, 1751

Member's Comments

No comment yet.

Related content which might interest you: Prognostic predictors of survival in patients with COPD hospitalized for an acute exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005 Prognostic features of disability in COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 57s Year: 2004 Validity of the diagnosis of pneumonia in hospitalised patients with COPD Source: ERJ Open Res, 5 (2) 00031-2019; 10.1183/23120541.00031-2019 Year: 2019 Biomarkers for the prognostic assessment and disease severity evaluation in community-acquired pneumonia (CAP) Source: Annual Congress 2010 - The prognosis of community-acquired pneumonia: old and new markers of severity Year: 2010 Updates in pneumonia in patients with COPD Source: International Congress 2014 – Ceremony for the ERS Best Publication Maurizio Vignola Award for Innovation in Pneumology 2014 - Clinical Year in Review II Year: 2014 Neutrophil CD 64 expression as a diagnostic marker of pneumonia in patients with acute COPD exacerbation Source: International Congress 2014 – Markers Year: 2014 Prognostic determinants in IPF patients with the histological features of usual interstitial pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 526s Year: 2001 Prognostic factors of COPD patients admitted in ICU for acute exacerbation requiring invasive ventilation Source: Annual Congress 2012 - Lung injury, respiratory muscles and mechanical ventilation Year: 2012 Community-acquired pneumonia in COPD patients: GOLD staging is a strong predicting factor of outcome of pneumonia Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Prognostic factors of mortality in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2003; 22: Suppl. 45, 239s Year: 2003 Predictive value of multiorgan imaging biomarkers for predicting exacerbations in COPD patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Clinical outcome and prognostic factors of acute respiratory failure due to pneumocystis pneumonia in non-HIV patients Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 The assessment of prognostic rules in patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2003; 22: Suppl. 45, 149s Year: 2003 Clinical features and outcome of COVID-19 pneumonia in haemodialysis patients Source: Virtual Congress 2021 – Diagnosis and management of COVID-19 Year: 2021 Prognostic predictors for survival in patients with COPD using cardiopulmonary testing Source: Eur Respir J 2002; 20: Suppl. 38, 285s Year: 2002 Prognostic significance of Glasgow Prognostic Score in patients with acute exacerbation of idiopathic pulmonary fibrosis Source: International Congress 2017 – Idiopathic pulmonary fibrosis (IPF): clinical problems Year: 2017 Clinical and demographic factors associated with pneumonia risk in a COPD patient cohort Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 Influence of pneumonia on the survival of patients with COPD Source: Virtual Congress 2020 – Diagnosis and management of COPD Year: 2020 Clinical epidemiology of pneumonia in hemodialysis patients Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Clinical assessment and staging of COPD exacerbations Source: International Congress 2014 – PG04 Update on COPD exacerbations Year: 2014